Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?

@article{Mandelblatt2013CognitiveEO,
  title={Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?},
  author={Jeanne S Mandelblatt and Arti Hurria and Brenna C. McDonald and Andrew J. Saykin and Robert A. M. Stern and John W. VanMeter and Meghan E McGuckin and Tiffany A. Traina and Neelima Denduluri and Scott R ichard Turner and Darlene V. Howard and Paul B. Jacobsen and Tim A. Ahles},
  journal={Seminars in oncology},
  year={2013},
  volume={40 6},
  pages={
          709-25
        }
}
There is a fairly consistent, albeit non-universal body of research documenting cognitive declines after cancer and its treatments. While few of these studies have included subjects aged 65 years and older, it is logical to expect that older patients are at risk of cognitive decline. Here, we use breast cancer as an exemplar disease for inquiry into the intersection of aging and cognitive effects of cancer and its therapies. There are a striking number of common underlying potential biological… CONTINUE READING
Tweets
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 32 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 170 REFERENCES

Similar Papers

Loading similar papers…